Suchergebnisse - "Lichtenstein, Steven J"

PubPharm (20)

1

Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas : a randomized clinical trial

enthalten in: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2008

von Whitson, J. | Roarty, J. | Vijaya, L. | +37

2

Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis

enthalten in: Clinical ophthalmology (Auckland, N.Z.) | 2008

von Lichtenstein, S. | Granet, D.

3

An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite

enthalten in: Clinical ophthalmology (Auckland, N.Z.) | 2007

von Granet, D. | Lichtenstein, S. | Onofrey, B. | +1

ErratumIn: Clin Ophthalmol. 2008 Mar;2(1):245 Dosage error in article text

4

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis

enthalten in: Advances in therapy | 2007

von Scoper, S. | Berdy, G. | Lichtenstein, S. | +9

5

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis

enthalten in: Advances in therapy | 2007

von Scoper, S. | Berdy, G. | Lichtenstein, S. | +9

6

Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones : clinical implications and a review of kinetics of kill studies

enthalten in: Advances in therapy | 2007

von Lichtenstein, S. | Wagner, R. | Jamison, T. | +2

7

Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: Clinical implications and a review of kinetics of kill studies

enthalten in: Advances in therapy | 2007

von Lichtenstein, S. | Wagner, R. | Jamison, T. | +2

8

Safety and tolerability of olopatadine 0.2% in children and adolescents

enthalten in: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2007

von Lichtenstein, S. | Pasquine, T. | Edwards, M. | +3

9

Safety and Tolerability of Olopatadine 0.2% in Children and Adolescents

enthalten in: Journal of ocular pharmacology and therapeutics | 2007

von Lichtenstein, S. | Pasquine, T. | Edwards, M. | +3

10

Pharmacology, clinical efficacy and safety of olopatadine hydrochloride

enthalten in: Expert review of clinical immunology | 2006

von Lichtenstein, S. | Abelson, M.